Ignite Creation Date:
2024-05-05 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00407511
Status:
COMPLETED
Last Update Posted:
2021-02-09
First Post:
2006-12-01
Brief Title:
Pregabalin Treatment Of Peripheral Neuropathic Pain Associated With Diabetic Peripheral NeP DPN Postherpetic Neuralgia PHN HIV-related NeP HIV and Chemotherapy Induced NeP
Sponsor:
Pfizers Upjohn has merged with Mylan to form Viatris Inc
Organization:
Pfizer
Study Overview
Official Title:
A Prospective Open Label Multi-Center Study Of Pregabalin In The Treatment Of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy Postherpetic Neuralgia HIV-Related Peripheral Neuropathic Pain And Chemotherapy Induced Peripheral Neuropathic Pain
Status:
COMPLETED
Status Verified Date:
2009-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Management of neuropathic pain associated with diabetic peripheral neuropathy post-herpetic neuralgia human immunodeficiency virus-related peripheral neuropathy and chemotherapy induced peripheral neuropathy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None